XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated Other Comprehensive Loss
Total
Balance at the beginning at Dec. 31, 2021 $ 17 $ 568,183 $ (9,535)   $ 558,665
Balance at the beginning (in shares) at Dec. 31, 2021 167,557,988        
Increase (Decrease) in Stockholders' Equity          
Net loss     (10,344)   (10,344)
Transaction costs   (12)     (12)
Stock options exercised   270     270
Stock options exercised (in shares) 6,212,964        
Stock-based compensation expense   1,596     1,596
Unrealized gain (loss) on marketable securities       $ (330) (330)
Balance at the end at Mar. 31, 2022 $ 17 570,037 (19,879) (330) 549,845
Balance at the end (in shares) at Mar. 31, 2022 173,770,952        
Balance at the beginning at Dec. 31, 2022 $ 18 577,603 (19,090) (3,159) 555,372
Balance at the beginning (in shares) at Dec. 31, 2022 176,007,184        
Increase (Decrease) in Stockholders' Equity          
Net loss     (19,158)   (19,158)
Stock options exercised   150     150
Stock options exercised (in shares) 1,679,954        
Stock-based compensation expense   2,222     2,222
Unrealized gain (loss) on marketable securities       885 885
Balance at the end at Mar. 31, 2023 $ 18 $ 579,975 $ (38,248) $ (2,274) $ 539,471
Balance at the end (in shares) at Mar. 31, 2023 177,687,138